The immunosuppressive molecule HLA-G and its clinical implications.
about
Some basic aspects of HLA-G biologyRole of non-classical MHC class I molecules in cancer immunosuppressionHuman mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applicationsImmunomodulatory properties of HLA-G in infectious diseasesHLA-G as a tolerogenic molecule in transplantation and pregnancy.Trophoblasts, invasion, and microRNA.Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French populationProteomic analysis of knock-down HLA-G in invasion of human trophoblast cell line JEG-3.Human leucocyte antigen-G (HLA-G) and its murine functional homolog Qa2 in the Trypanosoma cruzi Infection.HLA-G UTR haplotype conservation in the Malian population: association with soluble HLA-G.The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients.Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiationExpression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma.Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapyA combination of single nucleotide polymorphisms in the 3'untranslated region of HLA-G is associated with preeclampsia.RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma.The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia.The many faces of human leukocyte antigen-G: relevance to the fate of pregnancy.HLA class Ib in pregnancy and pregnancy-related disorders.Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.Down-expression of miR-152 lead to impaired anti-tumor effect of NK via upregulation of HLA-G.Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy.Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversity.Molecular characterization of MHC class II in the Australian invasive cane toad reveals multiple splice variants.Balancing immunity and tolerance: genetic footprint of natural selection in the transcriptional regulatory region of HLA-G.Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: A pilot study.High Amounts of Total and Extracellular Vesicle-Derived Soluble HLA-G are Associated with HLA-G 14-bp Deletion Variant in Women with Embryo Implantation Failure.Human leukocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment.Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes.Evaluation of membrane-bound and soluble forms of HLA-G in Systemic Sclerosis.Tumor immunotherapy: New aspects of natural killer cells.Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
P2860
Q26852671-C71E0FBA-0571-4E85-BBDB-1E66C1108394Q26999722-1DD6D121-F4C3-418B-B946-B0F0834896C5Q27004008-95BC2BAD-194A-4720-8557-055FCC8C91E1Q27013645-AE917358-5386-4232-B7E1-2024395FE7D1Q34038019-F5595577-E4B7-439C-85AC-C5EB2739D189Q34390117-FD9DB89A-F2DD-4639-85F1-D831A4B66641Q35034429-C8440936-A29A-49A2-AB34-CE3979DC65A4Q35042357-A19300EA-25CE-421B-9DEB-A7CB0F1CF672Q35061481-4906DF25-CF31-4BC7-A24A-E85B9572F270Q35077614-26848378-A5BE-48DF-99A5-23E84F7ADF2DQ35325312-E0B40695-CB67-411F-9A10-DA14DC114E02Q35390989-4083DCDE-88AE-4049-9091-F683277E5B22Q35878477-5DAE85FD-5E90-4A52-BD1E-18524D07F2AFQ36063731-E48B2534-9F64-43EC-8841-3A1D92B2D322Q36545749-9AD36954-EA1C-4ED5-9775-945440F28DF8Q36568297-FA5CC915-DDA1-4E02-A19F-8B1BD02C5E54Q37075173-567DD4F5-EA5E-4B68-B7DA-7856E4459F35Q37554783-6B1544F8-B9D4-4F81-B1DA-1BCE9F1B686FQ37602425-8E0134BC-1286-435D-AC5B-D6036FE54E78Q37704942-1DB75451-9754-491F-A7B7-C545C14626F3Q37704967-021FB9DB-9CE1-4509-B388-48A982292A9CQ38683065-6D94CFA7-876D-4968-BAF7-EAD2A6AD3D3CQ38839474-07080793-0B74-4731-8A70-6BD8DCE4E88DQ38999844-75D2BA4F-C3C5-4DF6-8030-61D746B2B690Q40097257-F9297788-7C6E-450D-AB15-3FAF7E791FD4Q40910254-DFFEE792-061E-4DE8-A03D-A8E8181A29F7Q40952458-8273F4D0-7FD1-45F7-ACF4-2FF9287B2729Q42243834-6F3376B5-0B8B-4FEC-B806-8F3BD5DA2B5EQ44171845-690A3ED3-B373-4EE7-9A6A-312A1C679689Q46541310-5DA96365-F281-44EF-825F-B6E1C59F7323Q46598900-C07F821B-C542-4991-BE24-5077753B5C91Q46800781-3F60B724-E745-4158-9FAF-9F07EFB571CDQ48146977-534C445C-6247-4437-AC2A-D70FAD8E593DQ48624670-79DC4B79-C5A9-4A95-998A-CB96DEA61DBDQ49335253-DFCAF1C1-6780-4A76-A179-03CE5E922117Q50204340-6CF12B21-92FE-4BA4-BCC9-4B8F72973C7BQ51066607-BA789B60-3A5D-4C31-80DA-34A5FD7C62B9Q52320287-32CC9839-A437-4DAF-B60E-56CFB7FCA703Q55107050-712586A3-6B23-4DA7-B5E5-0A32E0609895Q57490851-6AE3A929-A551-45D4-93F1-FCAA874A2243
P2860
The immunosuppressive molecule HLA-G and its clinical implications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The immunosuppressive molecule HLA-G and its clinical implications.
@en
type
label
The immunosuppressive molecule HLA-G and its clinical implications.
@en
prefLabel
The immunosuppressive molecule HLA-G and its clinical implications.
@en
P2093
P2860
P1476
The immunosuppressive molecule HLA-G and its clinical implications.
@en
P2093
Alvaro González
Edgardo D Carosella
Estibaliz Alegre
Joel LeMaoult
Peter A Horn
P2860
P356
10.3109/10408363.2012.677947
P50
P577
2012-04-26T00:00:00Z